These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1355993)

  • 21. Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.
    Du XL
    J Natl Cancer Inst; 2003 May; 95(9):683; author reply 684-5. PubMed ID: 12734321
    [No Abstract]   [Full Text] [Related]  

  • 22. [Questions and answers on adjuvant systemic therapy in breast carcinoma].
    Fey MF; Castiglione-Gertsch M
    Ther Umsch; 1996 Nov; 53(11):839-46. PubMed ID: 8984689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormonal manipulation in the adjuvant treatment of breast cancer.
    Honig SF; Swain SM
    Important Adv Oncol; 1993; ():103-23. PubMed ID: 8505047
    [No Abstract]   [Full Text] [Related]  

  • 24. [Adjuvant chemo-endocrine therapy for early breast cancer patients--review of the literature].
    Ikeda T; Masamura S; Hohjoh T; Kawaguchi M; Takayama S; Tokura H; Miyabe R; Kitajima M; Matsui A; Kikuchi K
    Nihon Rinsho; 2000 Apr; 58 Suppl():203-8. PubMed ID: 11025996
    [No Abstract]   [Full Text] [Related]  

  • 25. Meeting highlights: International consensus panel on the treatment of primary breast cancer.
    Love RR
    J Clin Oncol; 2002 Apr; 20(7):1955-6; author reply 1956-7. PubMed ID: 11919263
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prospective randomized trial on the efficacy of adjuvant endocrine therapy for ER-positive breast cancer patients after radical mastectomy].
    Jiang Z; Song S; Liu X
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):420-2. PubMed ID: 11810777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of adjuvant hormone therapy in breast cancer].
    Semiglazov VF; Ivanov VG; Ivanova OA; Moiseenko VM; Tsyrlina EV; Bozhok AA
    Vopr Onkol; 1996; 42(1):56-61. PubMed ID: 8686245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [What is the benefit of adjuvant therapy in breast cancer?].
    Sauer H
    Fortschr Med; 1992 Nov; 110(30):16-8, 20. PubMed ID: 1468737
    [No Abstract]   [Full Text] [Related]  

  • 29. 'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer--efficacy overview.
    Buzdar AU;
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):399-403. PubMed ID: 14623537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adjuvant therapy of breast cancer].
    Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
    Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
    [No Abstract]   [Full Text] [Related]  

  • 31. Adjuvant endocrine therapy in premenopausal women with breast cancer.
    González Martín A; de la Cruz S; Márquez R
    Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():43-7. PubMed ID: 20711666
    [No Abstract]   [Full Text] [Related]  

  • 32. Aromatase inhibitors for the endocrine adjuvant treatment of breast cancer.
    Ravdin P
    Lancet; 2002 Jun; 359(9324):2126-7. PubMed ID: 12090973
    [No Abstract]   [Full Text] [Related]  

  • 33. Increasing Precision in Adjuvant Therapy for Breast Cancer.
    Hudis CA; Dickler M
    N Engl J Med; 2016 Aug; 375(8):790-1. PubMed ID: 27557306
    [No Abstract]   [Full Text] [Related]  

  • 34. Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conference.
    Rabaglio M; Aebi S; Castiglione-Gertsch M
    Lancet Oncol; 2007 Oct; 8(10):940-9. PubMed ID: 17913663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant systemic therapy for breast cancer.
    Harris DT
    Semin Oncol; 1995 Dec; 22(6):553-70. PubMed ID: 8539632
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of relapse of breast cancer after adjuvant systemic therapy--review and guidelines for future research.
    Rubens RD; Bajetta E; Bonneterre J; Klijn JG; Lønning PE; Paridaens R
    Eur J Cancer; 1994; 30A(1):106-11. PubMed ID: 8142150
    [No Abstract]   [Full Text] [Related]  

  • 37. Rationale for combining chemotherapy and hormonal therapy in breast cancer.
    Sertoli MR; Scarsi PG; Rosso R
    J Steroid Biochem; 1985 Dec; 23(6B):1097-103. PubMed ID: 3841574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The EBCTCG overview of adjuvant therapy of breast cancer. What are the implications for future studies? Early Breast Cancer Trialists' Collaborative Group.
    Gray R; Clarke M; Collins R; Peto R
    Ann N Y Acad Sci; 1993 Nov; 698():339-48. PubMed ID: 8279773
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor angiogenesis in women with node-positive breast cancer.
    Folkman J
    Cancer J Sci Am; 1995; 1(2):106-8. PubMed ID: 9166461
    [No Abstract]   [Full Text] [Related]  

  • 40. [A randomized trial of endocrine therapy, chemotherapy, and chemo-endocrine therapy in advanced breast cancer].
    Tashiro H; Nomura Y; Hisamatsu K
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2369-73. PubMed ID: 2260873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.